NCT01923675

Brief Summary

  1. 1.To determine the effect of spectacles with a red blocking filter on myopia progression in children.
  2. 2.To determine the effect of spectacles with a holographic diffuser that spreads incident light rays over an angle of 0.5 degrees on myopia progression in children
  3. 3.To determine the combined effects of spectacles with a red blocking filter and a diffuser that spreads incident light over an angle of 0.5 degrees on myopia progression in children.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 15, 2013

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2013

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

August 14, 2019

Status Verified

August 1, 2019

Enrollment Period

4.1 years

First QC Date

August 13, 2013

Last Update Submit

August 12, 2019

Conditions

Keywords

myopianearsightednessaxial elongation of the eyerefractive error

Outcome Measures

Primary Outcomes (1)

  • Myopia progression measured by rate of axial elongation of the eye

    The axial length of both eyes will be measured before wearing the experimental eyeglasses, then once every three months thereafter for 18 months, and again 6 months after subjects stop wearing the study eye glasses. The rate of axial elongation will be calculated.

    every 3 months for 18 months

Secondary Outcomes (1)

  • Myopia progression measured by cycloplegic autorefraction.

    18 months

Study Arms (4)

color blocking tint

EXPERIMENTAL

Spectacles with red-blocking tint subjects will wear glasses daily for 6 months and have

Other: Spectacles with red-blocking tint

holographic diffuser

OTHER

Spectacles with color neutral tint subjects will wear glasses daily for 6 months and have

Other: Spectacles with holographic diffuser and color neutral tint

diffuser & color blocking tint

OTHER

Spectacles with holographic diffuser and red-blocking tint subjects will wear glasses daily for 6 months and have

Other: Spectacles with holographic diffuser and red-blocking tint

holographic diffuser and neutral tint

OTHER

Spectacles with holographic diffuser and color neutral tint subjects will wear glasses daily for 6 months and have

Other: Spectacles with color neutral tint

Interventions

Eyeglasses will have lenses that will correct refractive error for each subject, and will have a tint that blocks red light.

color blocking tint

Eyeglasses will correct refractive error for each subject but will have a holographic diffuser applied to the surface and will have a color neutral filter to adjust the light intensity reaching the eyes to be the same as for groups 1 and3.

holographic diffuser

Eyeglasses will correct refractive error for each subject and will be tinted to block red light, and will have a holographic diffuser to blur the image.

diffuser & color blocking tint

Eyeglasses will correct refractive error for each subject and will have a color neutral tint to adjust the light intensity reaching the eyes so it is the same as for groups 1 and 3.

holographic diffuser and neutral tint

Eligibility Criteria

Age8 Years - 13 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • nearsighted having a refractive error of at least -0.5 diopters
  • myopia progression at least -.50 D per year in previous year
  • astigmatism and anisometropia not more than 1.5 D
  • distance monocular acuity 6/6 or better
  • near monocular acuity of 0.4 M or better
  • stereoacuity not more than 40 sec of arc at 40 cm
  • able to respond to subjective testing
  • no contact lens use during the study
  • able to comply with wearing the experimental lenses daily for 18 months
  • able to have axial length measurements accurately on the Zeiss Intraocular Lens Master
  • willing to donate a blood sample or a buccal swab for genetic analysis
  • can be refracted to 20/20 or 20/15

You may not qualify if:

  • glaucoma, amblyopia, strabismus
  • ocular disease
  • developmental delay
  • history of wearing bifocal lenses
  • any type of eye surgery
  • color vision deficiency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington

Seattle, Washington, 98109, United States

Location

Related Publications (9)

  • Carkeet A, Saw SM, Gazzard G, Tang W, Tan DT. Repeatability of IOLMaster biometry in children. Optom Vis Sci. 2004 Nov;81(11):829-34. doi: 10.1097/01.opx.0000145020.33250.c0.

    PMID: 15545808BACKGROUND
  • Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA. 2003 Oct 15;290(15):2057-60. doi: 10.1001/jama.290.15.2057. No abstract available.

    PMID: 14559961BACKGROUND
  • Grosvenor T. Why is there an epidemic of myopia? Clin Exp Optom. 2003 Sep;86(5):273-5. doi: 10.1111/j.1444-0938.2003.tb03122.x. No abstract available.

    PMID: 14558848BACKGROUND
  • Gwiazda J, Hyman L, Hussein M, Everett D, Norton TT, Kurtz D, Leske MC, Manny R, Marsh-Tootle W, Scheiman M. A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1492-500. doi: 10.1167/iovs.02-0816.

    PMID: 12657584BACKGROUND
  • Ip JM, Rose KA, Morgan IG, Burlutsky G, Mitchell P. Myopia and the urban environment: findings in a sample of 12-year-old Australian school children. Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3858-63. doi: 10.1167/iovs.07-1451. Epub 2008 May 9.

    PMID: 18469186BACKGROUND
  • Rein DB, Zhang P, Wirth KE, Lee PP, Hoerger TJ, McCall N, Klein R, Tielsch JM, Vijan S, Saaddine J. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006 Dec;124(12):1754-60. doi: 10.1001/archopht.124.12.1754.

    PMID: 17159036BACKGROUND
  • Saw SM, Gazzard G, Shih-Yen EC, Chua WH. Myopia and associated pathological complications. Ophthalmic Physiol Opt. 2005 Sep;25(5):381-91. doi: 10.1111/j.1475-1313.2005.00298.x.

    PMID: 16101943BACKGROUND
  • Saw SM, Katz J, Schein OD, Chew SJ, Chan TK. Epidemiology of myopia. Epidemiol Rev. 1996;18(2):175-87. doi: 10.1093/oxfordjournals.epirev.a017924. No abstract available.

    PMID: 9021311BACKGROUND
  • Vitale S, Sperduto RD, Ferris FL 3rd. Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004. Arch Ophthalmol. 2009 Dec;127(12):1632-9. doi: 10.1001/archophthalmol.2009.303.

    PMID: 20008719BACKGROUND

MeSH Terms

Conditions

MyopiaRefractive Errors

Interventions

Eyeglasses

Condition Hierarchy (Ancestors)

Eye Diseases

Intervention Hierarchy (Ancestors)

LensesOptical DevicesEquipment and Supplies

Study Officials

  • Jay Neitz, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 13, 2013

First Posted

August 15, 2013

Study Start

November 1, 2013

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

August 14, 2019

Record last verified: 2019-08

Locations